The 3 Top Pharma Stocks to Buy in September 2024
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of…
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of…
Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair. The drug discovery process is…
There has been a noticeable shift in the stock market over the last two months. Investors are moving away from former high-flying large- and mega-cap stocks into discounted small-cap names that the…
The tech stock selloff in July surprised the market but not those investors who were paying attention. As far back as April, Goldman Sachs (NYSE:GS | GS Price Prediction) warned of the…
Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in your portfolio, but also because when you invest in them, you’re investing…
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson, Kenvue and Medtronic.
Friday's top analyst upgrades and downgrades included Builders FirstSource, CVS Health, DHT, Incyte, McDonald's, Newell Brands, PacWest Bancorp, Wingstop and ZoomInfo Technologies.
Wednesday's top analyst upgrades and downgrades included BP, ConocoPhillips, Equity Residential, Exxon Mobil, Global Payments, Kroger, Microsoft, NRG Energy, RingCentral, Valero Energy, Wayfair, Wendy's and Workday.
Tuesday's top analyst upgrades and downgrades included AT&T, Baxter International, Centene, Darden Restaurants, Lennar, L3 Harris Technologies, MGM Resorts International, Nvidia and Vertex Pharmaceuticals.
Thursday's top analyst upgrades and downgrades included Analog Devices, Aptiv, CF Industries, Ford, Mosaic, Park Hotels & Resorts, Patterson-UTI Energy, Pinterest, Plug Power, Salesforce, Snap, Temper Sealy, Tesla, Twilio and Urban Outfitters.
Wednesday's top analyst upgrades and downgrades included Allbirds, Amazon.com, American Eagle Outfitters, Canopy Growth, Citizens Financial, Cleveland-Cliffs, Etsy, Deere, LyondellBasell Industries, Medtronic, PayPal, Steel Dynamics and Truist Financial.
Monday's top analyst upgrades and downgrades included Bill.com, Block, Cigna, Crocs, CommScope, Dish Network, Foot Locker, Gap, Graphic Packaging, Ingersoll Rand, Moderna, Penn National Gaming, Shopify and Zillow.
Tuesday's top analyst upgrades and downgrades included Amgen, Array Technologies, Boeing, Carvana, DocuSign, Enterprise Products Partners, Fiserv, Johnson Controls, Monster Beverage, Nvidia, PayPal, PG&E, T-Mobile and Uber Technologies.
Tuesday's top analyst upgrades and downgrades included Analog Devices, Baxter, BorgWarner, Caesars Entertainment, CarMax, Chevron, Hertz Global, Li Auto, Starbucks, Tesla and Twitter.
Friday's top analyst upgrades and downgrades included Biogen, Devon Energy, Freeport-McMoRan, HIVE Blockchain, Hyatt Hotels, Infinera, Intuitive Surgical, KB Home, Li Auto, S&P Global and Vertex Pharmaceuticals.